Dr. Rajesh Ponugupati. “EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 23, no. 2, May 2016, pp. 237-46, https://doi.org/10.53555/am143177.